EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Role of m6A RNA Methylation in Ischemic Stroke

Yayun Xu, Wenqiang Liu, Lijie Ren

Molecular Neurobiology · 2024-09 · 61 (9) · 6997-7008

DOI: 10.1007/s12035-024-04029-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Neurobiology, online erschienen am 16.02.2024. Verfasst von Yayun Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Adenosine. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Science and Technology Innovation Commission of Shenzhen, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic stroke is a prominent contributor to global morbidity and mortality rates. The intricate and diverse mechanisms underlying ischemia-reperfusion injury remain poorly comprehended. RNA methylation, an emerging epigenetic modification, plays a crucial role in regulating numerous biological processes, including immunity, DNA damage response, tumorigenesis, metastasis, stem cell renewal, adipocyte differentiation, circadian rhythms, cellular development and differentiation, and cell division. Among the various RNA modifications, N6-methyladenosine (m6A) modification stands as the most prevalent in mammalian mRNA. Recent studies have demonstrated the crucial involvement of m6A modification in the pathophysiological progression of ischemic stroke. This review aims to elucidate the advancements in ischemic stroke-specific investigations pertaining to m6A modification, consolidate the underlying mechanisms implicated in the participation of m6A modification during the onset of ischemic stroke, and deliberate on the potential of m6A modification as a viable therapeutic target for ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeAdenosineHumansAnimalsMethylationRNARNA Methylation

Stichwörter der Autor:innen

Ischemic strokeMethylation-related enzymesPathogenesisTherapeutic targetm6A modification

Substanzen

AdenosineN-methyladenosineRNA

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, 230000, China.
  • The Key Laboratory of Anti-Inflammatory and Immune Medicines, Ministry of Education, Hefei, 230000, China.
  • Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China. 13631605966@126.com.

Förderung

  • Science and Technology Innovation Commission of Shenzhen
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Xu, Y., Liu, W., & Ren, L. (2024). Role of m6A RNA Methylation in Ischemic Stroke. Molecular Neurobiology, 61(9), 6997-7008. https://doi.org/10.1007/s12035-024-04029-3

Vancouver

Xu Y, Liu W, Ren L. Role of m6A RNA Methylation in Ischemic Stroke. Molecular Neurobiology. 2024;61(9):6997-7008. doi:10.1007/s12035-024-04029-3

BibTeX
@article{Xu2024,
  author = {Xu, Yayun and Liu, Wenqiang and Ren, Lijie},
  title = {Role of m6A RNA Methylation in Ischemic Stroke},
  journal = {Molecular Neurobiology},
  year = {2024},
  volume = {61},
  number = {9},
  pages = {6997--7008},
  doi = {10.1007/s12035-024-04029-3}
}
Kostenlos starten →